NSEDCP
IMMU

NJ State Employees Deferred Compensation Plan’s Immunomedics Inc IMMU Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,000
Closed -$1.27M – 509
2020
Q3 		$1.27M Hold
15,000
– – 0.23% 102
2020
Q2 		$532K Hold
15,000
– – 0.1% 201
2020
Q1 		$202K Hold
15,000
– – 0.05% 371
2019
Q4 		$317K Buy
+15,000
New +$265K 0.05% 388

NJ State Employees Deferred Compensation Plan's IMMU Position: Q4 2020 in Review

NJ State Employees Deferred Compensation Plan sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 15,000 shares — an estimated $1.27M sold.

NJ State Employees Deferred Compensation Plan first reported a position in IMMU in Q4 2019 and held it in 4 quarters. The position peaked at $1.27M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • NJ State Employees Deferred Compensation Plan reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 15,000 Immunomedics Inc shares in Q4 2020, an estimated $1.27M.
  • NJ State Employees Deferred Compensation Plan first reported a position in Immunomedics Inc in Q4 2019 and held it in 4 quarters.
  • NJ State Employees Deferred Compensation Plan's Immunomedics Inc position peaked at $1.27M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2020, filed 2 Feb 2021.